Search results for "blood viscosity"

showing 10 items of 47 documents

Monitoring of rheologic variables during postoperative high-dose brachytherapy for uterine cancer.

2004

Oxygenation of tumor tissue has recently been assed an important prerequisite for the effectiveness of radiotherapy in cervical cancer. Hyperviscosity is a common phenomenon in malignancy and a cause of reduced oxygen transport capacity that would favour tissue hypoxia. Hemorheological variables were serially tested preoperatively, during four cycles of fractionated adjuvant IR192 HDR after loading radiation (HDR-AL) of the vaginal vault (weekly intervals), and 6 months postoperatively in patients with cervical (n=12) and endometrial cancer (n=26). Women who were scheduled for benign tumor surgery served as controls (n=29). Preoperatively, in cervical and endometrial cancer patients, mean …

0301 basic medicineErythrocyte Aggregationmedicine.medical_specialtymedicine.medical_treatmentBrachytherapyBrachytherapyUrologyUterine Cervical Neoplasms030204 cardiovascular system & hematologyHysterectomy03 medical and health sciencesLeukocyte Count0302 clinical medicineUterine cancermedicineHumansAgedCervical cancerbusiness.industryPlatelet CountEndometrial cancerOxygen transportFibrinogenHematologyGeneral MedicineMiddle Agedmedicine.diseaseBlood ViscosityCombined Modality TherapyCell HypoxiaSurgeryEndometrial NeoplasmsRadiation therapy030104 developmental biologyHemorheologyVaginal vaultFemaleRadiotherapy AdjuvantbusinessBiomarkersClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort : novel results show menopause-re…

2018

Supplemental Digital Content is available in the text

0301 basic medicineOncologyestradiolivaihdevuodetNeutrophilsBlood count0302 clinical medicineSurveys and QuestionnairesFSHLongitudinal Studiesmenopausal status2. Zero hungerEstradiolvalkosolutApplied MathematicsObstetrics and Gynecologyta3141ta3142Middle AgedMenstruation3. Good health17β-EstradiolMenopauseCohortComputingMethodologies_DOCUMENTANDTEXTPROCESSINGFemaleMenopauselihaskuntoestrogeenitmedicine.medical_specialtyGeneral MathematicsAffect (psychology)Statistics Nonparametric03 medical and health sciencesohjelmoitunut solukuolema17b-Estradiolneutrophil-to-lymphocyte ratioInternal medicinemedicineHumansLymphocyte CountAnalysis of VarianceChi-Square Distributionbusiness.industryOriginal Articlesleucocyte countmedicine.diseaseCross-Sectional Studies030104 developmental biologyApoptosisMultivariate AnalysisLinear Modelsblood viscosityFollicle Stimulating Hormonebusiness030217 neurology & neurosurgeryFollow-Up StudiesHormoneMenopause: The Journal of The North American Menopause Society
researchProduct

Reflections on the unexpected laboratory finding of hemorheological alterations observed in some haematological disorders

2021

Hyperviscosity syndrome is a clinical condition characterized by the slowing of blood flow through the vessels and it may be associated with several diseases. The nosographic classification of primary hyperviscosity conditions (Wells classification 1970) divided the primary hyperviscosity syndromes in polycythaemic, sclerocytemic and sieric. Recent and personal laboratory observations have highlighted an unexpected behaviour of the erythrocyte deformability observed in some haematological disorders such as polycythemia vera, multiple myeloma and monoclonal gammopathy of undetermined significance. The interest of this observation depends on the fact that up to now, according to the Wells cla…

0301 basic medicinemedicine.medical_specialtyLaboratory findingHyperviscosityMonoclonal gammopathy of undetermined significance030204 cardiovascular system & hematologyBiochemistryHyperviscosity syndromes03 medical and health sciences0302 clinical medicinePolycythemia veraMultiple myelomaErythrocyte DeformabilityHyperviscosity syndromemedicineAnimalsHumansIntensive care medicinePolycythemia VeraMultiple myelomabusiness.industryModels CardiovascularCell Biologymedicine.diseaseBlood Viscosity030104 developmental biologyAbnormalityCardiology and Cardiovascular MedicinebusinessMonoclonal gammopathy of undetermined significanceHaematological disorders
researchProduct

Rheological blood behavior is not only influenced by cardiovascular risk factors but also by aging itself. Research into 927 healthy Spanish Mediterr…

2013

It is not well-established whether the alterations that the hemorheological profile undergoes with aging are an effect of concomitant cardiovascular risk factors or are due to age itself. To clarify this issue, we investigated the effect of age on blood rheology in a population of 927 healthy subjects from eastern Spain aged between 16-85 years, divided into four age groups (<30, 30-44, 45-50, ≥60 years) with and without cardiovascular risk factors. We determined blood viscosity, corrected blood viscosity (BVc), plasma viscosity (PV), erythrocyte aggregation (EA), erythrocyte deformability (EEI60) and fibrinogen, along with glucose and plasma lipids. We found that corrected blood viscosity …

AdultBlood GlucoseErythrocyte AggregationMalemedicine.medical_specialtyAgingAdolescentPhysiologyBlood viscosityPopulationFibrinogenLogistic regressionErythrocyte aggregationYoung AdultRisk FactorsPhysiology (medical)Internal medicineMedicineErythrocyte deformabilityHumanseducationMean corpuscular volumeAgedAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryAge FactorsFibrinogenHematologyMiddle AgedLipidsEndocrinologyCardiovascular DiseasesSpainConcomitantImmunologyHemorheologyFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugClinical hemorheology and microcirculation
researchProduct

Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population

2006

Plasma viscosity (PV) constitutes an independent important predictor of initial and recurrent cardiac events and mortality. It has been suggested that there is a geographical variation in PV values related to coronary event rates. Little information exists regarding PV in Spain. Therefore, our objective was to determine PV in a large sample of randomly selected subjects from the Spanish population and to study which demographic or cardiovascular risk factors (CVRF) influence levels of PV in this population.1277 subjects (503 males, 774 females) aged 43+/-14 years (range: 20-70) were randomly selected from an Eastern Spanish population. These subjects were free of cardiovascular diseases and…

AdultBlood GlucoseMalemedicine.medical_specialtyMultivariate analysisPopulationPopulation GroupsRisk FactorsDiabetes mellitusInternal medicinemedicineHumansmedia_common.cataloged_instanceEuropean unionRisk factoreducationTriglyceridesAgedmedia_commoneducation.field_of_studyMediterranean Regionbusiness.industryHypertriglyceridemiaFibrinogenHematologyMiddle AgedBlood Viscositymedicine.diseaseObesityCholesterolEndocrinologyCardiovascular DiseasesSpainFemalebusinessBody mass indexBiomarkersDemographyThrombosis Research
researchProduct

Effects of sorbinicate and nicotinic acid on blood viscosity, red cell deformation and platelet function

1982

Summary Nicotinic acid (NA) and a retard derivative, sorbinicate, were investigated for their effects on blood rheology and platelet function, after oral administration, in two groups of patients with lower limb atherosclerosis obliterans — the second group having diabetes also. Red cell deformation and blood plasma viscosity were studied in the nondiabetic group (single dose of NA, 100 mg, and sorbinicate, 400 mg); release of platelet malondialdehyde (MDA) (single dose of NA, 100 mg, and sorbinicate, 800 mg), and the platelet regeneration time (before and after sorbinicate 400 mg × 3/die for 7 days) were studied in the diabetic group. Both drugs induced a significant improvement in red cel…

AdultBlood PlateletsMalemedicine.medical_specialtyErythrocytesTime FactorsBlood viscosityNiacinchemistry.chemical_compoundNEFAOral administrationMalondialdehydeInternal medicineDiabetes mellitusBlood plasmamedicineHumansSorbitolPlateletTriglyceridesPharmacologyRed CellChemistryNicotinic AcidsFibrinogenMiddle AgedBlood Viscositymedicine.diseaseMalondialdehydeCholesterolEndocrinologyBiochemistryFemalePharmacological Research Communications
researchProduct

Haemorheological parameters in young patients with acute myocardial infarction

2008

The role played by hemorheological alterations on acute myocardial infarction (AMI) in young patients remains a question of debate. We have carried out a case-control study of 84 AMI patients aged45 years and 135 sex and age matched controls, in which blood viscosity (BV), plasma viscosity (PV), erythrocyte aggregation (EA) performed with the Myrenne (EA0, EA1) and the Sefam aggregometer (Ta, AI10, gammaD), erythrocyte deformability (ED) along with fibrinogen (Fbg), C-reactive protein (CRP) and plasmatic lipids i.e. total cholesterol (T-Chol) and triglycerides (TG) were determined. AMI patients showed higher, Fbg, TG, EA0, EA1, IA10, gammaD and lower Ta than controls (p=0.029, p0.001, p=0.0…

AdultErythrocyte AggregationMaleRiskmedicine.medical_specialtyErythrocytesPhysiologyBlood viscosityMyocardial InfarctionErythrocyte aggregationErythrocyte DeformabilityPhysiology (medical)Internal medicineHumansMedicineErythrocyte deformabilityMyocardial infarctionbusiness.industryCase-control studyFibrinogenHematologyMiddle AgedBlood Viscositymedicine.diseaseC-Reactive ProteinCase-Control StudiesHemorheologyCardiologyPhysical therapyFemaleCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct

Metabolic alterations in morbid obesity. Influence on the haemorheological profile.

2011

There are few studies on haemorheological disturbances in morbidly obese patients. The role played by the metabolic syndrome on the rheological profile of morbidly obese subjects has not yet been established, and it is not clear whether morbidly obese, but "metabolically healthy", show rheological alterations. We aimed to determine the whole rheological profile in 136 morbidly obese patients and 136 normo-weight volunteers, along with plasma lipids, inflammatory and insulin resistance parameters. Patients had statistically higher glucose, triglycerides, HbA1c, leptin, insulin, HOMA, CRP, leucocytes, fibrinogen, plasma viscosity (p0.001, respectively), erythrocyte aggregation at 3 s-1 (p = 0…

AdultErythrocyte AggregationMalemedicine.medical_specialtyPhysiologymedicine.medical_treatmentInflammationFibrinogenErythrocyte aggregationBody Mass IndexInsulin resistancePhysiology (medical)Internal medicinemedicineHumansBlood CoagulationMetabolic Syndromebusiness.industryInsulinLeptinBody WeightHematologymedicine.diseaseBlood ViscosityObesityObesity MorbidEndocrinologyHemorheologyFemaleMetabolic syndromemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugClinical hemorheology and microcirculation
researchProduct

Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.

2007

It is not well established whether haemorheological alterations constitute independent risk factors for deep vein thrombosis (DVT).We have determined in 149 DVT patients and in 185 control subjects the body mass index (BMI), the haemorheological profile: blood viscosity (BV), plasma viscosity (PV), fibrinogen (Fg), erythrocyte aggregation (EA), erythrocyte deformability (ED) and plasma lipids. In the crude analysis BMI, Fg, PV, EA, triglycerides (TG) and ApoB were statistically higher and HDL cholesterol (HDL-Chol) statistically lower in DVT patients than in controls. No differences in BV and ED were observed.After BMI adjustment, Fg, PV and EA remained statistically higher in DVT cases tha…

AdultErythrocyte AggregationMalemedicine.medical_specialtyTime FactorsDeep veinBlood viscosityHyperlipidemiasFibrinogenGastroenterologyRisk AssessmentBody Mass IndexDeep vein thrombosis; Lipids; Obesity; HaemorheologyRisk FactorsInternal medicineDeep vein thrombosisErythrocyte DeformabilityOdds RatioMedicineHumanscardiovascular diseasesObesityRisk factorTriglyceridesUNESCO::CIENCIAS MÉDICAS ::Patología::TrombosisVenous Thrombosisbusiness.industryFibrinogenHematologyOdds ratioMiddle Agedmedicine.diseaseBlood ViscosityThrombosisLipidsSurgeryHaemorheologymedicine.anatomical_structureCholesterolCase-Control StudiesHemorheologyHemorheologyFemalebusinessBody mass index:CIENCIAS MÉDICAS ::Patología::Trombosis [UNESCO]medicine.drugThrombosis and haemostasis
researchProduct

Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia

2020

: In this case report, we examine the behavior of plasma viscosity, explored at high and low shear rates, and erythrocyte aggregation in two patients with congenital afibrinogenemia, a clinical disorder firstly described in 1920 and that has an estimated incidence of 1 : 1-200 0000. The two hemorheological parameters examined by us showed a marked decrease in both patients, in one of whom erythrocyte aggregation was even undetectable. Keeping in mind that spontaneous thrombosis (venous and arterial) has been often described in congenital afibrinogenemia, it can be hypothesized that the decrease in plasma viscosity and erythrocyte aggregation might cause a reduction of the endothelial synthe…

AdultErythrocyte Aggregationmedicine.medical_specialty030204 cardiovascular system & hematologyErythrocyte aggregationNitric oxidePlasmaYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineShear stressHumansPlasma viscositybusiness.industryPlasma viscosity afibrinogenemiaHematologyGeneral MedicineMiddle AgedAfibrinogenemiaBlood Viscositymedicine.diseaseCongenital afibrinogenemiaEndocrinologychemistryFemaleStress MechanicalbusinessSpontaneous thrombosis030215 immunology
researchProduct